| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
46,716 |
37,487 |
$2.11M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
29,756 |
23,448 |
$1.42M |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
15,209 |
12,528 |
$1.15M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
10,454 |
9,632 |
$875K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
23,486 |
20,494 |
$716K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
16,315 |
5,082 |
$350K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
4,689 |
4,046 |
$211K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,407 |
2,209 |
$199K |
| 99460 |
|
2,538 |
2,250 |
$184K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,919 |
1,430 |
$108K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
4,568 |
3,676 |
$104K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
3,225 |
2,701 |
$93K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,631 |
1,330 |
$81K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
2,630 |
2,193 |
$68K |
| 99222 |
Initial hospital care, per day, moderate complexity |
1,851 |
1,410 |
$67K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,179 |
1,502 |
$60K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
5,509 |
2,814 |
$57K |
| 99233 |
Prolong inpt eval add15 m |
1,244 |
263 |
$47K |
| 96161 |
|
9,301 |
7,700 |
$36K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
843 |
473 |
$34K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,830 |
2,345 |
$31K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
294 |
277 |
$28K |
| 99223 |
Prolong inpt eval add15 m |
439 |
341 |
$26K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
838 |
637 |
$20K |
| 87428 |
|
325 |
266 |
$17K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,898 |
1,737 |
$17K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
162 |
102 |
$14K |
| 99468 |
|
15 |
12 |
$9K |
| 99464 |
|
176 |
151 |
$9K |
| 99462 |
|
185 |
159 |
$6K |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
52 |
51 |
$6K |
| J2785 |
Injection, regadenoson, 0.1 mg |
154 |
98 |
$6K |
| 87807 |
|
670 |
537 |
$6K |
| 93000 |
|
2,318 |
1,532 |
$5K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
533 |
419 |
$4K |
| 36415 |
Collection of venous blood by venipuncture |
3,434 |
2,715 |
$4K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
418 |
131 |
$3K |
| 95811 |
|
34 |
27 |
$2K |
| 0071A |
|
46 |
45 |
$2K |
| 99219 |
|
24 |
17 |
$1K |
| 93298 |
|
123 |
120 |
$1K |
| 99215 |
Prolong outpt/office vis |
32 |
26 |
$1K |
| 90473 |
|
84 |
82 |
$1K |
| 92567 |
|
92 |
83 |
$917.36 |
| 94010 |
|
145 |
112 |
$884.29 |
| 0072A |
|
25 |
25 |
$864.73 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
78 |
71 |
$807.84 |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
12 |
12 |
$790.59 |
| 99220 |
|
12 |
12 |
$768.57 |
| 90670 |
|
8,428 |
7,232 |
$743.98 |
| 93017 |
|
198 |
129 |
$740.01 |
| 93018 |
|
274 |
199 |
$700.53 |
| 93016 |
|
227 |
157 |
$697.22 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
43 |
16 |
$688.66 |
| 82962 |
|
419 |
365 |
$579.06 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
107 |
50 |
$561.67 |
| 90716 |
|
710 |
646 |
$542.88 |
| 99152 |
|
240 |
188 |
$420.00 |
| 90461 |
|
14,988 |
13,122 |
$400.86 |
| 90707 |
|
709 |
646 |
$314.72 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
77 |
59 |
$225.66 |
| 92557 |
|
12 |
12 |
$224.56 |
| 71045 |
Radiologic examination, chest; single view |
14 |
12 |
$186.37 |
| 93925 |
|
15 |
15 |
$173.56 |
| 90686 |
|
3,406 |
3,099 |
$165.58 |
| 90688 |
|
373 |
298 |
$137.30 |
| 92551 |
|
15 |
12 |
$124.93 |
| 90698 |
|
5,584 |
4,623 |
$107.00 |
| 90680 |
|
7,694 |
6,334 |
$94.78 |
| 90744 |
|
1,277 |
977 |
$84.14 |
| G2066 |
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results |
12 |
12 |
$83.91 |
| 94664 |
|
14 |
12 |
$81.90 |
| 93244 |
|
32 |
16 |
$69.94 |
| 93242 |
|
32 |
16 |
$55.23 |
| 90633 |
|
3,444 |
3,199 |
$52.01 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
531 |
438 |
$50.86 |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
556 |
449 |
$49.45 |
| 81003 |
|
56 |
38 |
$46.34 |
| 90647 |
|
698 |
660 |
$26.23 |
| 93296 |
|
13 |
12 |
$19.91 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
80 |
62 |
$16.45 |
| 81002 |
|
26 |
26 |
$15.71 |
| 1160F |
|
8,429 |
5,712 |
$0.00 |
| 3078F |
|
8,488 |
6,031 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
7,370 |
5,699 |
$0.00 |
| 1159F |
|
7,854 |
5,205 |
$0.00 |
| 4004F |
|
4,272 |
3,371 |
$0.00 |
| 90671 |
|
979 |
616 |
$0.00 |
| 90687 |
|
296 |
169 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
2,352 |
1,824 |
$0.00 |
| 3077F |
|
2,482 |
1,566 |
$0.00 |
| 3725F |
|
476 |
359 |
$0.00 |
| 1158F |
|
169 |
165 |
$0.00 |
| 91300 |
|
109 |
96 |
$0.00 |
| 90648 |
|
2,942 |
2,402 |
$0.00 |
| 90715 |
|
60 |
55 |
$0.00 |
| 90710 |
|
237 |
222 |
$0.00 |
| 90672 |
|
283 |
281 |
$0.00 |
| 90685 |
|
752 |
668 |
$0.00 |
| 99072 |
|
24 |
14 |
$0.00 |
| G8598 |
Aspirin or another antiplatelet therapy used |
50 |
26 |
$0.00 |
| 90734 |
|
44 |
44 |
$0.00 |
| G8421 |
Bmi not documented and no reason is given |
18 |
17 |
$0.00 |
| 90380 |
|
26 |
26 |
$0.00 |
| 90661 |
|
17 |
17 |
$0.00 |
| 3075F |
|
1,557 |
975 |
$0.00 |
| 3008F |
|
15,114 |
10,696 |
$0.00 |
| 90723 |
|
3,707 |
3,124 |
$0.00 |
| 3074F |
|
7,054 |
5,100 |
$0.00 |
| 99024 |
|
176 |
119 |
$0.00 |
| 1036F |
|
13,852 |
9,986 |
$0.00 |
| 1157F |
|
65 |
63 |
$0.00 |
| 1126F |
|
1,424 |
1,148 |
$0.00 |
| 3079F |
|
2,671 |
1,695 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
2,748 |
2,213 |
$0.00 |
| 90620 |
|
64 |
59 |
$0.00 |
| 1111F |
|
607 |
477 |
$0.00 |
| 1125F |
|
543 |
423 |
$0.00 |
| G8419 |
Bmi documented outside normal parameters, no follow-up plan documented, no reason given |
389 |
302 |
$0.00 |
| 1034F |
|
1,514 |
966 |
$0.00 |
| 90677 |
|
891 |
847 |
$0.00 |
| 1035F |
|
160 |
97 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
101 |
50 |
$0.00 |
| 90651 |
|
124 |
119 |
$0.00 |
| 3080F |
|
750 |
486 |
$0.00 |
| 90656 |
|
51 |
51 |
$0.00 |
| 4010F |
|
40 |
17 |
$0.00 |
| 90660 |
|
29 |
29 |
$0.00 |
| 90696 |
|
210 |
197 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
17 |
12 |
$0.00 |
| 1170F |
|
49 |
25 |
$0.00 |